Please confirm topic selection

Are you sure you want to trigger topic in your Anconeus AI algorithm?

Please confirm action

You are done for today with this topic.

Would you like to start learning session with this topic items scheduled for future?

Updated: Jun 15 2024

Antivirals

  • Antivirals
    • Blocks Viral Attachment, Penetration, or Uncoating
        • Prevents Viral Uncoating
        • Name of Drug
        • Key Indication(s)
        • Key Toxicity
        • Amantadine
        • Rimantadine
        • Influenza A
        • Livedo reticularis
        • Ataxia
        • Fusion Inhibitors
        • Name of Drug
        • Key Indication(s)
        • Key Toxicity
        • Enfurvirtide
        •  Maraviroc
        • HIV
        • Skin reaction
    • Viral DNA Polymerase Inhibitors
        • Name of Drug
        • Key Indication(s)
        • Key Toxicity
        • Acyclovir
        •  Valacyclovir
        • Famiciclovir
        •  HSV
        • VZV
        • EBV
        • Crystalline nephropathy that can lead to acute renal failure
        • Ganciclovir
        • CMV
        • Neutropenia
        • Leukopenia
        • Thrombocytopenia
        • Renal toxicity
        • Foscarnet
        • Second-line drug for CMV and HSV
        • Seizures
        • Nephrotoxicity
        • Electrolyte abnormalities
        • Cidofovir
        • Second-line drug for CMV and HSV
        • Nephrotoxicity
    • Viral RNA Polymerase Inhibitors
        • Name of Drug
        • Key Indication(s)
        • Key Toxicity
        • Ribavirin
        • Chronic hepatitis C
        • RSV
        • Viral hemorrhagic fevers
        • Bone marrow suppression
        • Teratogenic
    • Reverse Transcriptase Inhibitors (RTIs)
        • Nucleoside RTIs
        • Name of Drug
        • Key Indication(s)
        • Key Toxicity
        • Zidovudine
        • Didanosine
        • Zalcitabine
        • Lamivudine
        •  Stavudine
        • HAART (HIV)
        • Bone marrow suppression
        • Neuropathy
        • Lactic acidosis
        • Anemia (zidovudine)
        • Pancreatitis (didanosine) 
        • Non-Nucleoside RTIs
        • Name of Drug
        • Key Indication(s)
        • Key Toxicity
        • Nevirapine
        •  Efavirenz
        • HAART (HIV)
        • Rash
        • Hepatotoxicity
        • Dysphoric dreams (efavirenz)
    • Protease Inhibitors
        • Name of Drug
        • Key Indication(s)
        • Key Toxicity
        • Saquinavir
        •  Ritonavir
        • Indinavir
        •  Nelfinavir
        • Amprenavir
        • HAART (HIV)
        • Hyperglycemia
        • Hyperlipidemia
        • Lipodystrophy
        • GI intolerance
        • Hematuria (indinavir)
        • Nephropathy (indinavir)
    • Blocks Viral Release
        • Name of Drug
        • Key Indication(s)
        • Key Toxicity
        • Oseltamivir
        • Zanamivir
        • Influenza A and B
        • Flu-like Syndrome
        • Nausea
        • Vomiting
Card
1 of 0
Question
1 of 1
Private Note

Attach Treatment Poll
Treatment poll is required to gain more useful feedback from members.
Please enter Question Text
Please enter at least 2 unique options
Please enter at least 2 unique options
Please enter at least 2 unique options